Hader Walter J, Mackay Mark, Otsubo Hiroshi, Chitoku Shiro, Weiss Shelly, Becker Lawrence, Snead O Carter, Rutka James T
Division of Neurosurgery, Department of Surgery, The Hospital for Sick Children, University of Toronto, Ontario, Canada.
J Neurosurg. 2004 Feb;100(2 Suppl Pediatrics):110-7. doi: 10.3171/ped.2004.100.2.0110.
The authors conducted a study to determine seizure-related outcomes in a group of pediatric patients with pathologically proven focal cortical dysplasia (FCD) treated by focal cortical resections and multiple subpial transections (MSTs).
The authors performed a retrospective review of pediatric patients in whom surgery was conducted to treat medically refractory epilepsy secondary to cortical dysplasia between April 1989 and January 2001. Diagnostic studies included preoperative scalp electroencephalography (EEG), magnetic resonance (MR) imaging, positron emission tomography (PET), and magnetoencephalography (MEG). Intraoperative electrocorticography (ECoG) or extraoperative subdural grid EEG monitoring was performed in all patients. Seizure outcome was classified using the Engel scheme. The authors analyzed nine data points and compared these with seizure outcome, including seizure semiology, MR imaging, PET and MEG data, as well as location of resection, intracranial video-EEG findings, MSTs, postresection ECoG data, and histological findings. The authors analyzed data obtained in 39 children in whom the follow-up interval after epilepsy surgery was at least 18 months. Patients had suffered epilepsy for a mean of 7.7 years prior to surgical intervention and their mean age at treatment was 9.6 years (range 2 months-18 years). A good seizure-related outcome was demonstrated in 28 patients (72%), including 21 (54%) who were free of seizures (Engel Class I) and seven (18%) in whom seizures were rare (Engel Class II). In 11 patients seizure-related outcome was less favorable, including six (15%) with worthwhile improvement involving some seizures (Engel Class III) and five (13%) with no postoperative seizure improvement (Engel Class IV). There was no significant correlation between seizure outcome and data related to seizure characteristics, MR imaging, PET scanning, MEG, location of resection, intracranial video-EEG, postresection ECoG, and histological findings. Eight (50%) of 16 patients who underwent MSTs in addition to incomplete resection of FCD experienced a good outcome (Engel Class I and II). Twenty (87%) of 23 patients in whom resection of FCD was complete and in whom MSTs were not performed experienced a good seizure outcome (p < 0.05).
Complete resection of FCD results in good seizure outcome in a majority of children. When conducted in conjunction with incomplete cortical resection, MSTs do not improve seizure outcome in patients with FCD. Focal cortical dysplasia located outside of eloquent cortex and complete excision of the lesion are the most important predictors of seizure outcome.
作者开展了一项研究,以确定一组经病理证实为局灶性皮质发育不良(FCD)的儿科患者接受局灶性皮质切除术和多处软膜下横切术(MSTs)后的癫痫相关结局。
作者对1989年4月至2001年1月间因皮质发育不良导致药物难治性癫痫而接受手术治疗的儿科患者进行了回顾性研究。诊断性检查包括术前头皮脑电图(EEG)、磁共振(MR)成像、正电子发射断层扫描(PET)和脑磁图(MEG)。所有患者均进行了术中皮质脑电图(ECoG)或术外硬膜下网格EEG监测。癫痫结局采用恩格尔方案进行分类。作者分析了9个数据点,并将其与癫痫结局进行比较,包括癫痫发作症状学、MR成像、PET和MEG数据,以及切除部位、颅内视频EEG结果、MSTs、切除后ECoG数据和组织学结果。作者分析了39例癫痫手术后随访间隔至少18个月的儿童的数据。患者在手术干预前平均癫痫发作7.7年,治疗时的平均年龄为9.6岁(范围2个月至18岁)。28例患者(72%)显示出良好的癫痫相关结局,包括21例(54%)无癫痫发作(恩格尔I级)和7例(18%)癫痫发作罕见(恩格尔II级)。11例患者的癫痫相关结局较差,包括6例(15%)有一些癫痫发作但有显著改善(恩格尔III级)和5例(13%)术后癫痫发作无改善(恩格尔IV级)。癫痫结局与癫痫发作特征、MR成像、PET扫描、MEG、切除部位、颅内视频EEG、切除后ECoG和组织学结果相关数据之间无显著相关性。16例除FCD不完全切除外还接受了MSTs的患者中有8例(50%)结局良好(恩格尔I级和II级)。23例FCD切除完全且未进行MSTs的患者中有20例(87%)癫痫结局良好(p<0.05)。
FCD的完全切除在大多数儿童中可带来良好的癫痫结局。与不完全皮质切除联合进行时,MSTs并不能改善FCD患者的癫痫结局。位于明确皮质之外的局灶性皮质发育不良和病变的完全切除是癫痫结局的最重要预测因素。